{"task_id": "c0bf67a2c86c0b66", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 68/464)", "text": "10% for Streptococcal endocarditis\nEndocarditis\n53\n\n--- Page 75 ---\nRelated Topics\nAortic Regurgitation (p. 49)\nMitral Regurgitation (p. 51)\nTricuspid Regurgitation (p. 51)\nMANAGEMENT\nEMPIRIC ANTIBIOTIC THERAPY\nnative valve and\nnon IDU (ampicillin 2 g IV q4h or cloxacillin 2 g IV q4h\nplusgentamicin1mg/kgIVq8h,orvancomycin1gIVq12h\nplus gentamicin 1 mg/kg IV q8h), native valve and IDU\n(cloxacillin 2 g IV q4h plus gentamicin 1 mg/kg IV q8h or\nvancomycin 1 g IV q12h plusgentamicin 1 mg/kg IV q8h),\nprosthetic valve (vancomycin 1 g IV q12h plus gentami\ncin 1 mg/kg IV q8h plus rifampin 600 mg PO daily)\nTARGETED ANTIBIOTIC THERAPY (please refer to\nthe Sanford guide to antimicrobial therapy)\nStreptococci (penicillin G 2 3MU IV q4h or ceftriax\none 2 g IV/IM q24h \u00044 weeks. Gentamicin 1 mg/kg\nIV q24h \u00042 weeks may be added in certain circum\nstances to shorten the course by 2 weeks). Penicil\nlin sensitive Enterococci (ampicillin 2 g IV q4h or\nvancomycin 1 g IV q12h \u00044 6 weeks, plus gentami\ncin 1 mg/kg IV q8h \u00044 6 weeks for native valve).\nPenicillin resistant Enterococci (vancomycin 1 g IV\nq12h \u00046 weeks, plus gentamicin 1 mg/kg IV q8h \u00046\nweeks for native valve). S. aureus (cloxacillin 2 g IV\nq6h or nafcillin or oxacillin 3 g IV q6h or cefazolin 2 g\nIV q8h \u00042 6 weeks (depending on right or left\nsided valve) \u0007 gentamicin 1 mg/kg\nIV q8h\n\u00043 5days: for native valve). MRSA (vancomycin\n1 g IV q12h \u00046 weeks for native valve). HACEK\n(ceftriaxone 2 g IV/IM q24h or ampicillin sulbactam\n3 g IV q6h or ciprofloxacin 500 mg PO BID \u00044 weeks).\nFor prosthetic valve infection, therapy is usually\nlonger (by 2 4 weeks) with gentamicin\nSURGERY\nvalvular replacement (<10% reinfec\ntion rate. See indications below)\nTREATMENT ISSUES\nINDICATIONS FOR SURGERY\nin the acute period,\nrefractory congestive heart failure is the most impor\ntant indication. Other indications include perivalvular\nextension of infection, abscess, microbiologic failure,\ninfection with fungi or untreatable pathogens, Sta\nphylococci on a prosthetic valve, two major emboli\nevents and one major embolus event with residual\nlarge mobile vegetation\nOVERALL RECOMMENDATIONS FOR ENDOCARDI\nTIS PROPHYLAXIS\nonly given to patients with the\nhighest risk of developing endocarditis, which include\nthe following:\n\u0002\nHIGH-RISK CARDIAC CONDITIONS\nprosthetic cardiac\nvalve, prosthetic material used for cardiac valve\nrepair, unrepaired cyanotic congenital heart dis\nease, completely repaired cyanotic congenital\nheart disease with residual defects at the site or\nadjacent to the site of the prosthetic device, car\ndiac transplant recipients with valvulopathy, pre\nvious endocarditis\n\u0002\nPROCEDURES\n\u0002\nORAL CAVITY\nmanipulation of gingival or peri\npical region of teeth, perforation of oral mucosa\n\u0002\nRESPIRATORY TRACT\ntonsillectomy, adenoidect\nomy, bronchoscopy with a rigid bronchoscope,\nor flexible bronchoscopy if biopsied\n\u0002\nGI/GU\nTRACT\nprophylaxis\ngenerally\nnot\nrecommended\n\u0002\nPROPHYLAXIS REGIMENS\ngive one of the following\n30 60 min prior to procedure: amoxicillin 2 g PO/\nIM/IV, cefazolin 1 g IV/IM, ceftriaxone 1 g IV/IM,\ncephalexin 2 g PO, clindamycin 600 mg PO/IM/IV,\nazithromycin 500 mg PO, clarithromycin 500 mg PO\nPeripheral Vascular Disease\nNEJM 2007 356:12\nDIFFERENTIAL DIAGNOSIS OF CLAUDICATION\nARTERIAL\n\u0002\nATHEROSCLEROSIS\n\u0002\nINTRALUMINAL OCCLUSION\nembolism, thrombo\nsis, dissection, adventitial cystic disease, arterial\nfibrodysplasia, arterial tumor, occluded limb\naneurysm\n\u0002\nVASCULITIS\nTakayasu\u2019s arteritis, temporal arter\nitis, thromboangiitis obliterans\n\u0002\nVASOSPASM\n\u0002\nDRUGS\nergot\nDIFFERENTIAL DIAGNOSIS OF CLAUDICATION\n(CONT\u2019D)\n\u0002\nFIBROSIS\niliac endofibrosis, radiation fibrosis,\nretroperitoneal fibrosis\n\u0002\nTRAUMA\nVENOUS\nDVT,\nthrombophlebitis,\nvenous\ncongestion\nNEUROPATHIC\nspinal\nstenosis,\nperipheral\nneuropathy\nOTHERS\narthritis (hips, knees), compartment\nsyndrome\n54\nPeripheral Vascular Disease", "text_length": 3853, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 68/464)", "type": "chunk", "chunk_index": 67, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.329328", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.330127", "status": "complete", "chunks_added": 2}